Albert Bourla, CEO of drugmaker Pfizer, has tested positive for Covid-19 and has “very mild symptoms,” he said in a پیغامات پیر کو.
“I would like to let you know that I have tested positive for #COVID19,” Bourla wrote. “I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.”
Pfizer to acquire antiviral biopharma with HQ in Durham for up to $525M
He said that he is “confident I will have a speedy recovery,” due to how far the world has come in efforts to battle the coronavirus and expressed gratitude for his colleagues who worked to make vaccines and treatments available.
Pfizer shared the same information in a company بیان.
Pfizer’s vaccine was the first Covid-19 vaccine in the United States to receive US Food and Drug Administration ہنگامی استعمال کی اجازت in December 2020. Since then, it has received مکمل منظوری for use in people age 16 and up and is authorized for other ages groups down to بچوں as young as six months. It is also authorized as a بوسٹر dose for those age 5 and older and as a second booster dose for adults age 50 and older or people who are immunocompromised.
Pfizer is also working on updated shots to target the Omicron variant, with the company saying they could be available in the early fall depending on signoff by federal officials.
Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
Bourla shared information about the company’s oral antiviral Covid-19 treatment, Paxlovid, in his messages on Twitter.
Paxlovid was granted ہنگامی استعمال کی اجازت by the FDA in December 2021. Paxlovid can be used for treatment of mild to moderate Covid-19 in people age 12 and up and who weight at least 88 pounds and are at risk of severe disease.
President Joe Biden took Paxlovid when he مثبت تجربہ کیا for Covid-19 last month.
The-CNN-Wire™ & © 2022 Cable News Network, Inc.، ایک WarnerMedia کمپنی۔ جملہ حقوق محفوظ ہیں.
US moves to broaden access to Pfizer antiviral drug for treatment of COVID
